Received Feb 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 255t2 | IM / LA |
Patient had previously received the vaccine on 12/17/2023, so this was an extra unnecessary dose. Patient has experience no other symptoms except for normal injection site reactions (soreness)